Vor Biopharma, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Vor Biopharma, Inc. | VOR - NASDAQ |
$16.00-$18.00 | $18.00 | $42.02 | 9.8 million | 2/5/2021 |
| Goldman Sachs, Evercore ISI, Barclays, Stifel | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-15 Terms Added 2021-02-01 | ||||||
Vor Biopharma, Inc. Quote & Chart - Click for current quote - VOR
IPO Boutique aggregates information on public companies and private companies, such as "VOR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Vor Biopharma, Inc. (adapted from Vor Biopharma, Inc. prospectus):
The mission of Vor Biopharma is to develop transformative treatments for patients suffering from hematological malignancies.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
The mission of Vor Biopharma is to develop transformative treatments for patients suffering from hematological malignancies.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VOR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.